<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">114024</id>
  <title nil="true"/>
  <common-name>Distigmine3,3'-{Hexane-1,6-diylbis[(methylcarbamoyl)oxy]}bis(1-methylpyridin-1-ium) dibromide</common-name>
  <description>Distigmine3,3'-{Hexane-1,6-diylbis[(methylcarbamoyl)oxy]}bis(1-methylpyridin-1-ium) dibromide belongs to the methylpyridines, a subclass of pyridines and derivatives within the organic compounds. It is an organoheterocyclic compound with the formula C22H32Br2N4O4. With an average molecular weight of 576.33 g/mol, Distigmine3,3'-{Hexane-1,6-diylbis[(methylcarbamoyl)oxy]}bis(1-methylpyridin-1-ium) dibromide is a heavy molecule.</description>
  <cas nil="true"/>
  <pubchem-id>27522</pubchem-id>
  <chemical-formula>C22H32Br2N4O4</chemical-formula>
  <weight nil="true"/>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-04-05T21:36:31Z</created-at>
  <updated-at type="dateTime">2026-04-05T21:36:31Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>[Br-].[Br-].CN(CCCCCCN(C)C(=O)OC1=C[N+](C)=CC=C1)C(=O)OC1=C[N+](C)=CC=C1</moldb-smiles>
  <moldb-formula>C22H32Br2N4O4</moldb-formula>
  <moldb-inchi>InChI=1/C22H32N4O4.2BrH/c1-23-13-9-11-19(17-23)29-21(27)25(3)15-7-5-6-8-16-26(4)22(28)30-20-12-10-14-24(2)18-20;;/h9-14,17-18H,5-8,15-16H2,1-4H3;2*1H/q+2;;/p-2</moldb-inchi>
  <moldb-inchikey>GJHSNEVFXQVOHR-UHFFFAOYSA-L</moldb-inchikey>
  <moldb-average-mass type="decimal">576.33</moldb-average-mass>
  <moldb-mono-mass type="decimal">574.0790297</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp nil="true"/>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM109917</chemdb-id>
  <dsstox-id>DTXSID60935985</dsstox-id>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id>NS00087031</susdat-id>
  <iupac>3,3'-{hexane-1,6-diylbis[(methylcarbamoyl)oxy]}bis(1-methylpyridinium) dibromide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Pyridines and derivatives</klass>
  <subklass>Methylpyridines</subklass>
  <paper-count type="integer">0</paper-count>
  <sync-id>CED0120802</sync-id>
  <structure-inchikey>GJHSNEVFXQVOHR-UHFFFAOYSA-L</structure-inchikey>
  <structure-fingerprint>800000000800000000000000000000000000000000000000000000000000200200020000008000000000000000000001020000000000000000000000200000000000000000000020000040001100008000000000000000080000010000000000000000004000000000000000000000000000001000000000000040000000800000000000010000100000000000000800000000010000000000000000000000000000080000000010000000000000000000000000000000000000000000000000000000000800040002000000040040000200000000000000000000000000000040000000010400000001000000000000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAgAAAAHwAAAIABIyACAAAA/yMgAgAAAP8G
AGAAAAABAwcAKAAAAAMDBgBgAAAAAgIGAGAAAAACAgYAYAAAAAICBgBgAAAA
AgIGAGAAAAACAgYAYAAAAAICBwAoAAAAAwMGAGAAAAABAwYAKAAAAAMECAAo
AAAAAwIIACgAAAADAgZAKAAAAAMEBkBoAAAAAwMBB2AqAAAAAQMEBgBgAAAA
AQMGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGACgAAAADBAgAKAAAAAMC
CAAoAAAAAwIGQCgAAAADBAZAaAAAAAMDAQdgKgAAAAEDBAYAYAAAAAEDBkBo
AAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBCwIDAAMEAAQFAAUGAAYHAAcIAAgJ
AAkKAAoLAAoMIAwNKAIMDiAODyAPEGgMEBFoDBESABETaAwTFGgMFBVoDAMW
IBYXKAIWGCAYGSAZGmgMGhtoDBscABsdaAwdHmgMHh9oDBUPaAwfGWgMQgIA
AAAGEBETFBUPBhobHR4fGRcEAAAAAAAAABY=
</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T04:43:46Z</structure-indexed-at>
</compound>
